| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.524 | 0.025 | 0.524 | 5 Hydroxytryptamine release inhibitor | 0.293 0.173 CID_5896 0.346 0.119 CID_154700124 0.468 0.044 CID_14371 | ||
| 0.518 | 0.026 | 0.518 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.35 0.151 CID_5896 0.321 0.185 CID_154700124 0.386 0.113 CID_14371 | ||
| 0.535 | 0.048 | 0.721 | Caspase 9 stimulant | 0.367 0.132 CID_5896 0.488 0.065 CID_154700124 0.721 0.021 CID_14371 | CID_14371 | |
| 0.492 | 0.032 | 0.522 | Histamine release inhibitor | 0.286 0.132 CID_154700124 0.522 0.022 CID_14371 | CID_14371 | |
| 0.443 | 0.007 | 0.443 | Alpha-N-acetylglucosaminidase inhibitor | 0.223 0.028 CID_5896 0.282 0.018 CID_154700124 0.318 0.014 CID_14371 | ||
| 0.408 | 0.015 | 0.408 | Anesthetic general | 0.244 0.053 CID_5896 0.234 0.057 CID_154700124 0.353 0.023 CID_14371 | ||
| 0.378 | 0.022 | 0.378 | Interleukin agonist | 0.216 0.106 CID_5896 0.25 0.079 CID_154700124 0.32 0.039 CID_14371 | ||
| 0.386 | 0.032 | 0.386 | Interleukin 2 agonist | 0.32 0.061 CID_154700124 0.362 0.04 CID_14371 | ||
| 0.358 | 0.008 | 0.358 | 5 Hydroxytryptamine 1E antagonist | 0.196 0.136 CID_5896 0.191 0.142 CID_154700124 0.333 0.014 CID_14371 | ||
| 0.41 | 0.074 | 0.414 | Calcium channel L-type activator | 0.292 0.164 CID_154700124 0.414 0.072 CID_14371 | CID_14371 | |
| 0.371 | 0.043 | 0.371 | Aryl hydrocarbon receptor agonist | 0.349 0.048 CID_14371 | ||
| 0.391 | 0.065 | 0.396 | GABA C receptor rho-3 antagonist | 0.244 0.16 CID_5896 0.396 0.063 CID_14371 | CID_14371 | |
| 0.336 | 0.031 | 0.469 | Peroxidase inhibitor | 0.259 0.045 CID_5896 0.167 0.07 CID_154700124 0.469 0.012 CID_14371 | CID_14371 | |
| 0.325 | 0.023 | 0.381 | Tyrosine 3 hydroxylase inhibitor | 0.336 0.02 CID_5896 0.257 0.062 CID_154700124 0.381 0.01 CID_14371 | CID_14371 | |
| 0.324 | 0.043 | 0.324 | Superoxide dismutase inhibitor | 0.214 0.103 CID_5896 0.3 0.05 CID_14371 | ||
| 0.299 | 0.018 | 0.358 | NOS3 expression enhancer | 0.157 0.066 CID_5896 0.358 0.011 CID_14371 | CID_14371 | |
| 0.279 | 0.009 | 0.279 | Death-associated protein kinase 2 inhibitor | 0.215 0.025 CID_5896 0.207 0.03 CID_154700124 0.238 0.016 CID_14371 | ||
| 0.297 | 0.035 | 0.297 | Gastrin inhibitor | 0.197 0.153 CID_154700124 0.243 0.088 CID_14371 | ||
| 0.268 | 0.011 | 0.268 | Ferrochelatase inhibitor | 0.124 0.051 CID_5896 0.104 0.066 CID_154700124 0.123 0.051 CID_14371 | ||
| 0.279 | 0.031 | 0.279 | Neuropeptide Y2 antagonist | 0.223 0.085 CID_154700124 0.24 0.067 CID_14371 | ||
| 0.337 | 0.093 | 0.337 | Calpain 2 inhibitor | 0.22 0.171 CID_14371 | ||
| 0.256 | 0.016 | 0.327 | Hexokinase inhibitor | 0.171 0.057 CID_154700124 0.327 0.008 CID_14371 | CID_14371 | |
| 0.321 | 0.087 | 0.323 | Vasodilator, peripheral | 0.291 0.102 CID_154700124 0.323 0.086 CID_14371 | CID_14371 | |
| 0.235 | 0.007 | 0.235 | MAP3K9 inhibitor | 0.201 0.015 CID_5896 0.21 0.012 CID_14371 | ||
| 0.242 | 0.02 | 0.242 | 5 Hydroxytryptamine 3E antagonist | 0.164 0.158 CID_154700124 0.186 0.09 CID_14371 | ||
| 0.228 | 0.012 | 0.237 | Cyclooxygenase 3 inhibitor | 0.158 0.041 CID_154700124 0.237 0.01 CID_14371 | CID_14371 | |
| 0.253 | 0.037 | 0.289 | Neurotrophic factor enhancer | 0.155 0.131 CID_5896 0.187 0.09 CID_154700124 0.289 0.021 CID_14371 | CID_14371 | |
| 0.305 | 0.09 | 0.305 | Angiogenesis inhibitor | 0.289 0.098 CID_14371 | ||
| 0.256 | 0.049 | 0.256 | Platelet aggregation inhibitor | 0.165 0.111 CID_14371 | ||
| 0.272 | 0.068 | 0.333 | Transcription factor STAT3 inhibitor | 0.196 0.139 CID_154700124 0.333 0.039 CID_14371 | CID_14371 | |
| 0.213 | 0.014 | 0.278 | Carbonic anhydrase III inhibitor | 0.163 0.024 CID_5896 0.278 0.007 CID_14371 | CID_14371 | |
| 0.232 | 0.036 | 0.232 | 3C-like protease (Human coronavirus) inhibitor | 0.183 0.063 CID_14371 | ||
| 0.267 | 0.073 | 0.394 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.178 0.114 CID_154700124 0.394 0.04 CID_14371 | CID_14371 | |
| 0.268 | 0.075 | 0.332 | Transcription factor STAT inhibitor | 0.332 0.041 CID_14371 | CID_14371 | |
| 0.239 | 0.047 | 0.27 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.181 0.091 CID_5896 0.151 0.148 CID_154700124 0.27 0.034 CID_14371 | CID_14371 | |
| 0.28 | 0.092 | 0.42 | 12-Lipoxygenase inhibitor | 0.228 0.124 CID_5896 0.42 0.034 CID_14371 | CID_14371 | |
| 0.261 | 0.075 | 0.326 | DNA damaging | 0.326 0.048 CID_14371 | CID_14371 | |
| 0.231 | 0.048 | 0.231 | LIM domain kinase 1 inhibitor | 0.158 0.09 CID_14371 | ||
| 0.33 | 0.149 | 0.33 | DNA polymerase beta inhibitor | 0.329 0.15 CID_14371 | ||
| 0.19 | 0.013 | 0.19 | Papain-like protease (SARS coronavirus) inhibitor | 0.154 0.03 CID_154700124 0.176 0.018 CID_14371 | ||
| 0.196 | 0.025 | 0.196 | Platelet activating factor beta antagonist | 0.083 0.076 CID_14371 | ||
| 0.258 | 0.089 | 0.258 | Insulysin inhibitor | 0.213 0.139 CID_5896 0.219 0.131 CID_14371 | ||
| 0.201 | 0.036 | 0.201 | ATPase inhibitor | 0.178 0.061 CID_154700124 0.193 0.043 CID_14371 | ||
| 0.219 | 0.055 | 0.219 | Focal adhesion kinase 2 inhibitor | 0.146 0.137 CID_14371 | ||
| 0.247 | 0.084 | 0.247 | 5 Hydroxytryptamine uptake stimulant | 0.222 0.113 CID_14371 | ||
| 0.227 | 0.065 | 0.227 | MAP kinase kinase 2 inhibitor | 0.185 0.092 CID_14371 | ||
| 0.277 | 0.117 | 0.277 | Calcium channel activator | 0.26 0.135 CID_14371 | ||
| 0.201 | 0.043 | 0.201 | Phospholipase C inhibitor | 0.181 0.06 CID_5896 0.195 0.048 CID_14371 | ||
| 0.158 | 0.006 | 0.158 | Glycine receptor antagonist | 0.118 0.019 CID_5896 0.122 0.017 CID_154700124 0.157 0.006 CID_14371 | ||
| 0.224 | 0.073 | 0.248 | Peptidyltransferase inhibitor | 0.232 0.065 CID_154700124 0.248 0.052 CID_14371 | CID_14371 | |
| 0.177 | 0.026 | 0.178 | Sphingosine 1-phosphate receptor 5 antagonist | 0.178 0.026 CID_154700124 0.157 0.05 CID_14371 | CID_154700124 | |
| 0.154 | 0.01 | 0.154 | Glutamate (mGluR7) agonist | 0.104 0.053 CID_14371 | ||
| 0.175 | 0.034 | 0.175 | Platelet activating factor antagonist | |||
| 0.301 | 0.161 | 0.315 | DNA directed DNA polymerase inhibitor | 0.315 0.154 CID_14371 | CID_14371 | |
| 0.201 | 0.062 | 0.201 | Growth factor agonist | 0.168 0.106 CID_14371 | ||
| 0.158 | 0.024 | 0.158 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.085 0.073 CID_5896 0.099 0.055 CID_154700124 0.111 0.045 CID_14371 | ||
| 0.232 | 0.099 | 0.232 | 5 Hydroxytryptamine release stimulant | 0.167 0.157 CID_14371 | ||
| 0.19 | 0.057 | 0.213 | Succinate dehydrogenase inhibitor | 0.164 0.088 CID_5896 0.213 0.04 CID_14371 | CID_14371 | |
| 0.18 | 0.049 | 0.18 | Cyclin-dependent kinase 3 inhibitor | 0.156 0.084 CID_14371 | ||
| 0.174 | 0.043 | 0.174 | M17 leucyl aminopeptidase inhibitor | 0.159 0.05 CID_154700124 0.141 0.061 CID_14371 | ||
| 0.136 | 0.008 | 0.136 | Neuraminidase inhibitor | 0.101 0.015 CID_154700124 0.125 0.009 CID_14371 | ||
| 0.172 | 0.044 | 0.189 | CF transmembrane conductance regulator agonist | 0.137 0.102 CID_154700124 0.189 0.028 CID_14371 | CID_14371 | |
| 0.159 | 0.033 | 0.159 | Falcipain 3 inhibitor | 0.104 0.066 CID_14371 | ||
| 0.23 | 0.105 | 0.274 | Immunostimulant | 0.191 0.126 CID_154700124 0.274 0.087 CID_14371 | CID_14371 | |
| 0.22 | 0.095 | 0.22 | Calpain inhibitor | |||
| 0.151 | 0.026 | 0.151 | Catalase inhibitor | 0.087 0.044 CID_14371 | ||
| 0.15 | 0.027 | 0.15 | CDK3/cyclin E inhibitor | 0.103 0.082 CID_154700124 0.116 0.061 CID_14371 | ||
| 0.15 | 0.029 | 0.15 | UDP-glucose 4-epimerase inhibitor | 0.128 0.038 CID_5896 0.091 0.072 CID_154700124 0.138 0.033 CID_14371 | ||
| 0.151 | 0.03 | 0.153 | TRPA1 agonist | 0.153 0.029 CID_14371 | CID_14371 | |
| 0.13 | 0.01 | 0.13 | Neuraminidase (influenza) inhibitor | 0.097 0.017 CID_154700124 0.128 0.01 CID_14371 | ||
| 0.159 | 0.039 | 0.159 | Pregnane X receptor agonist | 0.131 0.097 CID_154700124 0.151 0.052 CID_14371 | ||
| 0.175 | 0.056 | 0.175 | Cyclin-dependent kinase 8 inhibitor | 0.124 0.111 CID_14371 | ||
| 0.159 | 0.04 | 0.159 | Adenylate cyclase inhibitor | 0.151 0.044 CID_154700124 0.151 0.044 CID_14371 | ||
| 0.14 | 0.022 | 0.14 | Telomerase inhibitor | 0.07 0.052 CID_154700124 0.124 0.025 CID_14371 | ||
| 0.194 | 0.078 | 0.194 | Death-associated protein kinase 3 inhibitor | 0.143 0.134 CID_14371 | ||
| 0.162 | 0.048 | 0.162 | Neuropeptide Y1 antagonist | 0.132 0.096 CID_14371 | ||
| 0.156 | 0.042 | 0.156 | Cathepsin H inhibitor | 0.104 0.099 CID_5896 | ||
| 0.163 | 0.05 | 0.163 | MAP kinase 3 inhibitor | 0.125 0.119 CID_5896 0.132 0.103 CID_14371 | ||
| 0.121 | 0.009 | 0.121 | NMDA receptor glycine site agonist | 0.07 0.036 CID_5896 0.084 0.026 CID_154700124 0.103 0.015 CID_14371 | ||
| 0.165 | 0.053 | 0.165 | Toll-Like receptor 9 antagonist | |||
| 0.155 | 0.044 | 0.195 | Alkylator | 0.195 0.028 CID_14371 | CID_14371 | |
| 0.2 | 0.089 | 0.2 | ErbB-1 antagonist | 0.174 0.126 CID_14371 | ||
| 0.19 | 0.08 | 0.231 | Non-steroidal antiinflammatory agent | 0.186 0.082 CID_5896 0.231 0.052 CID_14371 | CID_14371 | |
| 0.273 | 0.163 | 0.273 | MAP kinase kinase 6 inhibitor | 0.27 0.167 CID_14371 | ||
| 0.17 | 0.062 | 0.18 | Neurotensin receptor agonist | 0.18 0.05 CID_14371 | CID_14371 | |
| 0.149 | 0.041 | 0.149 | Death-associated protein kinase 1 inhibitor | 0.138 0.062 CID_14371 | ||
| 0.174 | 0.067 | 0.292 | Heat shock protein 90 alpha antagonist | 0.206 0.045 CID_5896 0.292 0.016 CID_14371 | CID_14371 | |
| 0.261 | 0.156 | 0.421 | 15-Lipoxygenase inhibitor | 0.297 0.134 CID_5896 0.421 0.066 CID_14371 | CID_14371 | |
| 0.151 | 0.047 | 0.151 | Nav1.3 sodium channel blocker | |||
| 0.162 | 0.059 | 0.162 | GABA C receptor rho-2 antagonist | 0.148 0.077 CID_14371 | ||
| 0.142 | 0.039 | 0.142 | DNA repair enzyme inhibitor | 0.108 0.103 CID_5896 0.133 0.05 CID_14371 | ||
| 0.147 | 0.045 | 0.147 | Sphingosine 1-phosphate receptor 2 antagonist | 0.147 0.045 CID_154700124 0.126 0.083 CID_14371 | ||
| 0.11 | 0.008 | 0.158 | Topoisomerase II beta inhibitor | 0.061 0.021 CID_154700124 0.158 0.005 CID_14371 | CID_14371 | |
| 0.13 | 0.031 | 0.137 | Anabolic | 0.103 0.058 CID_5896 0.115 0.044 CID_154700124 0.137 0.025 CID_14371 | CID_14371 | |
| 0.207 | 0.112 | 0.208 | DNA synthesis inhibitor | 0.208 0.11 CID_14371 | CID_14371 | |
| 0.121 | 0.026 | 0.121 | I kappa B kinase inhibitor | 0.12 0.026 CID_14371 | ||
| 0.204 | 0.111 | 0.204 | MAP kinase kinase 3 inhibitor | |||
| 0.128 | 0.035 | 0.149 | HIV-1 integrase (Overall Integration) inhibitor | 0.149 0.026 CID_14371 | CID_14371 | |
| 0.171 | 0.079 | 0.212 | Lipocortins synthesis antagonist | 0.212 0.049 CID_5896 0.171 0.079 CID_154700124 0.155 0.098 CID_14371 | CID_5896 | |
| 0.142 | 0.05 | 0.142 | Histone deacetylase class III inhibitor | 0.128 0.063 CID_14371 | ||
| 0.137 | 0.045 | 0.168 | MAO A inhibitor | 0.168 0.036 CID_14371 | CID_14371 | |
| 0.134 | 0.043 | 0.134 | MAP kinase kinase kinase inhibitor | |||
| 0.121 | 0.032 | 0.121 | Potassium channel activator | 0.082 0.072 CID_5896 0.098 0.05 CID_14371 | ||
| 0.137 | 0.047 | 0.137 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.105 | 0.017 | 0.105 | NMDA receptor agonist | 0.063 0.043 CID_154700124 0.081 0.028 CID_14371 | ||
| 0.099 | 0.013 | 0.103 | I kappa B kinase 2 inhibitor | 0.103 0.012 CID_14371 | CID_14371 | |
| 0.157 | 0.071 | 0.157 | Diuretic | 0.116 0.11 CID_14371 | ||
| 0.097 | 0.011 | 0.117 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.117 0.007 CID_14371 | CID_14371 | |
| 0.092 | 0.006 | 0.092 | Dihydroorotate oxidase inhibitor | 0.052 0.045 CID_5896 0.057 0.035 CID_154700124 0.082 0.01 CID_14371 | ||
| 0.194 | 0.109 | 0.23 | RNA-directed DNA polymerase inhibitor | 0.176 0.139 CID_154700124 0.23 0.064 CID_14371 | CID_14371 | |
| 0.122 | 0.037 | 0.168 | Prolactin inhibitor | 0.09 0.067 CID_154700124 0.168 0.016 CID_14371 | CID_14371 | |
| 0.116 | 0.031 | 0.116 | Neuropeptide Y antagonist | |||
| 0.19 | 0.106 | 0.194 | Nitric-oxide synthase stimulant | 0.194 0.1 CID_14371 | CID_14371 | |
| 0.147 | 0.064 | 0.147 | Histone deacetylase SIRT1 inhibitor | 0.121 0.09 CID_14371 | ||
| 0.143 | 0.061 | 0.143 | Ca2+-transporting ATPase inhibitor | 0.139 0.079 CID_5896 0.14 0.072 CID_154700124 0.137 0.087 CID_14371 | ||
| 0.141 | 0.059 | 0.173 | Toll-Like receptor 2 antagonist | 0.173 0.038 CID_14371 | CID_14371 | |
| 0.116 | 0.036 | 0.139 | Androgen antagonist | 0.107 0.042 CID_154700124 0.139 0.026 CID_14371 | CID_14371 | |
| 0.116 | 0.036 | 0.116 | Potassium channel (Voltage-sensitive) activator | |||
| 0.123 | 0.044 | 0.123 | Acetylcholine release stimulant | |||
| 0.173 | 0.096 | 0.173 | I kappa B kinase epsilon inhibitor | |||
| 0.124 | 0.047 | 0.124 | GABA C receptor agonist | 0.086 0.084 CID_5896 0.092 0.076 CID_14371 | ||
| 0.096 | 0.019 | 0.103 | Alcohol oxidase inhibitor | 0.066 0.031 CID_5896 0.103 0.017 CID_14371 | CID_14371 | |
| 0.183 | 0.108 | 0.225 | Cyclic AMP phosphodiesterase inhibitor | 0.16 0.136 CID_154700124 0.225 0.077 CID_14371 | CID_14371 | |
| 0.124 | 0.049 | 0.124 | GABA C receptor antagonist | 0.115 0.057 CID_5896 0.109 0.065 CID_14371 | ||
| 0.092 | 0.019 | 0.092 | NMDA 2C receptor antagonist | 0.062 0.042 CID_154700124 0.084 0.022 CID_14371 | ||
| 0.098 | 0.025 | 0.098 | CC chemokine 5 receptor agonist | 0.089 0.039 CID_14371 | ||
| 0.091 | 0.018 | 0.111 | Beta 3 adrenoreceptor antagonist | 0.111 0.012 CID_14371 | CID_14371 | |
| 0.223 | 0.151 | 0.238 | Antithrombotic | 0.238 0.136 CID_14371 | CID_14371 | |
| 0.107 | 0.035 | 0.143 | Carbonic anhydrase VI inhibitor | 0.083 0.053 CID_5896 0.143 0.022 CID_14371 | CID_14371 | |
| 0.143 | 0.071 | 0.143 | Vascular endothelial growth factor 3 antagonist | |||
| 0.221 | 0.149 | 0.341 | Transcription factor NF kappa B inhibitor | 0.292 0.098 CID_154700124 0.341 0.08 CID_14371 | CID_14371 | |
| 0.173 | 0.101 | 0.19 | Interleukin antagonist | 0.164 0.108 CID_154700124 0.19 0.09 CID_14371 | CID_14371 | |
| 0.093 | 0.022 | 0.093 | Secretase beta inhibitor | |||
| 0.118 | 0.048 | 0.131 | Carbonic anhydrase XV inhibitor | 0.131 0.039 CID_14371 | CID_14371 | |
| 0.118 | 0.049 | 0.118 | Mediator release inhibitor | 0.111 0.058 CID_14371 | ||
| 0.117 | 0.048 | 0.121 | Urease inhibitor | 0.106 0.06 CID_5896 0.121 0.044 CID_14371 | CID_14371 | |
| 0.114 | 0.045 | 0.114 | GABA C receptor rho-1 antagonist | 0.095 0.07 CID_14371 | ||
| 0.08 | 0.012 | 0.08 | CD45 antagonist | 0.078 0.013 CID_14371 | ||
| 0.072 | 0.005 | 0.072 | Melatonin antagonist | 0.028 0.02 CID_14371 | ||
| 0.098 | 0.032 | 0.138 | Keratolytic | 0.076 0.055 CID_5896 0.138 0.017 CID_14371 | CID_14371 | |
| 0.128 | 0.062 | 0.128 | Anesthetic local | 0.095 0.088 CID_14371 | ||
| 0.152 | 0.086 | 0.152 | Arachidonic acid antagonist | 0.123 0.122 CID_5896 0.152 0.086 CID_14371 | ||
| 0.251 | 0.186 | 0.251 | Transcription factor inhibitor | 0.216 0.213 CID_14371 | ||
| 0.122 | 0.057 | 0.123 | Caspase 3 inhibitor | 0.123 0.055 CID_14371 | CID_14371 | |
| 0.074 | 0.01 | 0.074 | Dihydroorotase inhibitor | 0.052 0.023 CID_14371 | ||
| 0.071 | 0.007 | 0.071 | Neuraminidase (Influenza A) inhibitor | 0.052 0.02 CID_154700124 0.066 0.009 CID_14371 | ||
| 0.112 | 0.048 | 0.167 | Creatine kinase inhibitor | 0.091 0.07 CID_5896 0.167 0.018 CID_14371 | CID_14371 | |
| 0.14 | 0.076 | 0.141 | Heat shock protein 70 antagonist | 0.141 0.071 CID_14371 | CID_14371 | |
| 0.097 | 0.034 | 0.118 | D-Ala-D-Ala ligase inhibitor | 0.118 0.015 CID_14371 | CID_14371 | |
| 0.084 | 0.022 | 0.093 | Androgen agonist | 0.063 0.038 CID_154700124 0.093 0.018 CID_14371 | CID_14371 | |
| 0.121 | 0.058 | 0.121 | Transcription factor STAT6 inhibitor | 0.118 0.063 CID_14371 | ||
| 0.107 | 0.045 | 0.107 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.139 | 0.079 | 0.139 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.088 | 0.027 | 0.088 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.119 | 0.059 | 0.137 | Photosensitizer | 0.099 0.091 CID_5896 0.137 0.04 CID_14371 | CID_14371 | |
| 0.107 | 0.048 | 0.107 | Electrolyte absorption antagonist | |||
| 0.085 | 0.027 | 0.085 | Histone deacetylase inhibitor | 0.059 0.056 CID_5896 | ||
| 0.207 | 0.149 | 0.207 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.098 | 0.041 | 0.178 | Topoisomerase II alpha inhibitor | 0.178 0.018 CID_14371 | CID_14371 | |
| 0.167 | 0.11 | 0.167 | Anticonvulsant | 0.154 0.124 CID_154700124 | ||
| 0.117 | 0.06 | 0.117 | Alpha 2b adrenoreceptor antagonist | 0.108 0.068 CID_14371 | ||
| 0.114 | 0.058 | 0.124 | Protein kinase C gamma inhibitor | 0.124 0.049 CID_14371 | CID_14371 | |
| 0.116 | 0.06 | 0.116 | 5 Hydroxytryptamine 3A agonist | |||
| 0.106 | 0.05 | 0.106 | Nitric-oxide synthase inhibitor | |||
| 0.089 | 0.033 | 0.089 | Check point kinase 1 inhibitor | 0.081 0.037 CID_14371 | ||
| 0.129 | 0.073 | 0.129 | Nav1.2 sodium channel blocker | |||
| 0.14 | 0.085 | 0.154 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.154 0.074 CID_14371 | CID_14371 | |
| 0.166 | 0.112 | 0.198 | Insulin sensitizer | 0.193 0.08 CID_154700124 0.198 0.075 CID_14371 | CID_14371 | |
| 0.059 | 0.005 | 0.059 | ATM kinase inhibitor | 0.038 0.021 CID_14371 | ||
| 0.089 | 0.036 | 0.089 | GABA aminotransferase inhibitor | 0.071 0.06 CID_154700124 0.08 0.046 CID_14371 | ||
| 0.094 | 0.042 | 0.094 | Acetylcholine nicotinic agonist | |||
| 0.063 | 0.013 | 0.063 | Purinergic P2X4 antagonist | 0.057 0.017 CID_14371 | ||
| 0.217 | 0.167 | 0.217 | Vasodilator, coronary | |||
| 0.136 | 0.086 | 0.136 | Cytidine deaminase inhibitor | |||
| 0.095 | 0.046 | 0.095 | Bromodomain-containing protein 2 inhibitor | |||
| 0.065 | 0.017 | 0.065 | Immunoglobulin Fc receptor antagonist | 0.06 0.025 CID_5896 0.052 0.049 CID_14371 | ||
| 0.072 | 0.024 | 0.072 | Potassium channel (Ca-activated) blocker | |||
| 0.073 | 0.025 | 0.073 | Cyclin D1 inhibitor | 0.068 0.031 CID_14371 | ||
| 0.102 | 0.055 | 0.102 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | |||
| 0.09 | 0.043 | 0.157 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.157 0.017 CID_14371 | CID_14371 | |
| 0.09 | 0.042 | 0.09 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.083 0.047 CID_14371 | ||
| 0.064 | 0.017 | 0.064 | Heparanase inhibitor | 0.058 0.027 CID_14371 | ||
| 0.136 | 0.089 | 0.136 | Adenylate cyclase stimulant | 0.128 0.106 CID_154700124 0.135 0.09 CID_14371 | ||
| 0.072 | 0.025 | 0.072 | Histone deacetylase SIRT3 inhibitor | |||
| 0.093 | 0.046 | 0.093 | Granulocyte macrophage colony stimulating factor agonist | 0.084 0.064 CID_14371 | ||
| 0.135 | 0.089 | 0.152 | Hemostatic | 0.152 0.065 CID_14371 | CID_14371 | |
| 0.057 | 0.011 | 0.057 | Nerve growth factor antagonist | 0.055 0.013 CID_154700124 | ||
| 0.113 | 0.067 | 0.132 | Protein kinase (CK2) alpha inhibitor | 0.132 0.054 CID_14371 | CID_14371 | |
| 0.049 | 0.004 | 0.049 | Melatonin receptor 1A antagonist | 0.013 0.011 CID_14371 | ||
| 0.05 | 0.005 | 0.05 | Melatonin 1 antagonist | 0.017 0.016 CID_14371 | ||
| 0.162 | 0.117 | 0.162 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.051 | 0.007 | 0.051 | Melatonin receptor 1A agonist | 0.032 0.027 CID_5896 0.032 0.027 CID_14371 | ||
| 0.123 | 0.079 | 0.137 | NADPH oxidase inhibitor | 0.137 0.064 CID_14371 | CID_14371 | |
| 0.127 | 0.086 | 0.175 | Protein kinase stimulant | 0.175 0.053 CID_154700124 0.114 0.099 CID_14371 | CID_154700124 | |
| 0.108 | 0.067 | 0.112 | Mucolytic | 0.112 0.062 CID_14371 | CID_14371 | |
| 0.115 | 0.074 | 0.115 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | |||
| 0.096 | 0.056 | 0.129 | Protein kinase C zeta inhibitor | 0.129 0.027 CID_14371 | CID_14371 | |
| 0.059 | 0.018 | 0.059 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.114 | 0.074 | 0.114 | Abl kinase inhibitor | |||
| 0.056 | 0.017 | 0.056 | Benzodiazepine antagonist | |||
| 0.073 | 0.034 | 0.073 | Glutamate (mGluR6) antagonist | 0.064 0.053 CID_5896 | ||
| 0.149 | 0.109 | 0.184 | Catenin beta inhibitor | 0.184 0.047 CID_14371 | CID_14371 | |
| 0.049 | 0.01 | 0.049 | Melatonin agonist | 0.032 0.024 CID_14371 | ||
| 0.079 | 0.04 | 0.079 | Glycine receptor agonist | 0.073 0.048 CID_5896 0.068 0.058 CID_154700124 0.07 0.055 CID_14371 | ||
| 0.11 | 0.071 | 0.11 | Interleukin 1b antagonist | |||
| 0.053 | 0.014 | 0.053 | Alpha 1d adrenoreceptor agonist | |||
| 0.083 | 0.045 | 0.088 | Porphobilinogen synthase inhibitor | 0.088 0.042 CID_14371 | CID_14371 | |
| 0.068 | 0.031 | 0.068 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.057 | 0.02 | 0.057 | Glutamate (mGluR group III) agonist | |||
| 0.047 | 0.01 | 0.047 | Melatonin 1 agonist | 0.032 0.025 CID_14371 | ||
| 0.064 | 0.028 | 0.064 | Nicotinic alpha7 receptor agonist | |||
| 0.195 | 0.158 | 0.229 | Thyroid hormone beta antagonist | 0.229 0.132 CID_14371 | CID_14371 | |
| 0.092 | 0.056 | 0.104 | Triose-phosphate isomerase inhibitor | 0.104 0.044 CID_5896 | CID_5896 | |
| 0.044 | 0.009 | 0.044 | Epoxide hydrolase 1 inhibitor | |||
| 0.061 | 0.027 | 0.061 | Dihydroorotate dehydrogenase inhibitor | 0.05 0.037 CID_14371 | ||
| 0.055 | 0.021 | 0.055 | Adenylate cyclase 1 inhibitor | |||
| 0.123 | 0.089 | 0.129 | Protein kinase C nu inhibitor | 0.129 0.083 CID_14371 | CID_14371 | |
| 0.082 | 0.048 | 0.082 | Interferon agonist | |||
| 0.049 | 0.015 | 0.049 | Phenylethanolamine N methyltransferase inhibitor | 0.037 0.036 CID_5896 0.04 0.028 CID_14371 | ||
| 0.055 | 0.022 | 0.055 | Carbonic anhydrase IV inhibitor | 0.037 0.036 CID_14371 | ||
| 0.051 | 0.018 | 0.051 | Histone deacetylase 7 inhibitor | 0.035 0.027 CID_5896 | ||
| 0.06 | 0.027 | 0.06 | DNA helicase inhibitor | 0.058 0.032 CID_14371 | ||
| 0.078 | 0.046 | 0.078 | GABA B receptor agonist | 0.076 0.05 CID_14371 | ||
| 0.047 | 0.015 | 0.047 | Potassium channel Kv1.1 blocker | |||
| 0.13 | 0.098 | 0.241 | Heat shock protein 90 antagonist | 0.154 0.071 CID_5896 0.241 0.023 CID_14371 | CID_14371 | |
| 0.089 | 0.057 | 0.089 | Histamine N-methyltransferase inhibitor | |||
| 0.077 | 0.046 | 0.077 | NMDA 2 receptor antagonist | 0.074 0.047 CID_14371 | ||
| 0.057 | 0.026 | 0.057 | Lysophosphatidic acid 3 receptor antagonist | 0.047 0.04 CID_14371 | ||
| 0.066 | 0.036 | 0.066 | 5 Hydroxytryptamine 5A antagonist | 0.063 0.04 CID_14371 | ||
| 0.049 | 0.019 | 0.061 | Dopamine D5 agonist | 0.061 0.011 CID_14371 | CID_14371 | |
| 0.077 | 0.048 | 0.077 | Histone deacetylase SIRT2 inhibitor | |||
| 0.099 | 0.07 | 0.13 | Expectorant | 0.13 0.044 CID_14371 | CID_14371 | |
| 0.07 | 0.041 | 0.07 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.195 | 0.166 | 0.234 | Thyroid hormone antagonist | 0.234 0.134 CID_14371 | CID_14371 | |
| 0.094 | 0.066 | 0.096 | Phosphodiesterase 6D inhibitor | 0.096 0.061 CID_14371 | CID_14371 | |
| 0.072 | 0.044 | 0.072 | Carbonic anhydrase VA inhibitor | 0.065 0.052 CID_14371 | ||
| 0.159 | 0.131 | 0.257 | Aldehyde oxidase inhibitor | 0.257 0.08 CID_14371 | CID_14371 | |
| 0.058 | 0.031 | 0.108 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.108 0.009 CID_14371 | CID_14371 | |
| 0.085 | 0.059 | 0.121 | NMDA receptor antagonist | 0.11 0.041 CID_154700124 0.121 0.035 CID_14371 | CID_14371 | |
| 0.148 | 0.122 | 0.148 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.139 0.13 CID_14371 | ||
| 0.056 | 0.031 | 0.056 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.078 | 0.053 | 0.087 | MAP kinase kinase 7 inhibitor | 0.087 0.031 CID_14371 | CID_14371 | |
| 0.093 | 0.068 | 0.097 | Sphingomyelinase inhibitor | 0.097 0.063 CID_5896 | CID_5896 | |
| 0.097 | 0.072 | 0.097 | Adenylate kinase inhibitor | |||
| 0.063 | 0.039 | 0.063 | Alpha 2 adrenoreceptor agonist | |||
| 0.053 | 0.029 | 0.053 | Potassium channel (Inward rectifier) activator | |||
| 0.051 | 0.028 | 0.051 | Potassium channel (ATP-sensitive) activator | |||
| 0.092 | 0.069 | 0.092 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.069 | 0.047 | 0.081 | Phenylalanine 4-hydroxylase inhibitor | 0.081 0.037 CID_5896 0.081 0.036 CID_14371 | CID_14371 | |
| 0.067 | 0.045 | 0.067 | Carbonic anhydrase V inhibitor | 0.061 0.052 CID_14371 | ||
| 0.043 | 0.021 | 0.043 | Delayed rectifier potassium channel activator | |||
| 0.043 | 0.021 | 0.043 | Potassium channel KCNQ activator | |||
| 0.029 | 0.008 | 0.029 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.099 | 0.078 | 0.099 | GABA receptor agonist | |||
| 0.046 | 0.024 | 0.046 | CDK5/p25 inhibitor | 0.039 0.031 CID_14371 | ||
| 0.048 | 0.027 | 0.048 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.064 | 0.044 | 0.064 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.026 | 0.006 | 0.026 | Alpha 2c adrenoreceptor agonist | |||
| 0.067 | 0.048 | 0.067 | Glutamate (mGluR7) antagonist | |||
| 0.065 | 0.046 | 0.074 | Beta adrenoreceptor antagonist | 0.074 0.033 CID_14371 | CID_14371 | |
| 0.081 | 0.062 | 0.102 | T cell inhibitor | 0.102 0.023 CID_154700124 | CID_154700124 | |
| 0.105 | 0.085 | 0.121 | MAO inhibitor | 0.121 0.074 CID_14371 | CID_14371 | |
| 0.026 | 0.007 | 0.026 | Neuraminidase (Influenza B) inhibitor | 0.023 0.011 CID_14371 | ||
| 0.091 | 0.072 | 0.091 | Vascular endothelial growth factor 1 antagonist | |||
| 0.046 | 0.027 | 0.046 | AICAR transformylase inhibitor | |||
| 0.114 | 0.095 | 0.114 | Toll-Like receptor antagonist | |||
| 0.041 | 0.022 | 0.041 | Progesterone antagonist | |||
| 0.072 | 0.054 | 0.072 | Vanilloid antagonist | |||
| 0.042 | 0.023 | 0.042 | Histone deacetylase 9 inhibitor | |||
| 0.042 | 0.024 | 0.042 | Histone deacetylase class I inhibitor | |||
| 0.148 | 0.13 | 0.148 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.144 0.136 CID_14371 | ||
| 0.058 | 0.04 | 0.058 | 5 Hydroxytryptamine 5 antagonist | 0.054 0.046 CID_14371 | ||
| 0.07 | 0.053 | 0.07 | Epoxide hydrolase inhibitor | |||
| 0.073 | 0.055 | 0.073 | Potassium channel (Tandem pore domain) blocker | |||
| 0.04 | 0.023 | 0.04 | Diamine oxidase inhibitor | |||
| 0.06 | 0.042 | 0.06 | Potassium channel intermediate-conductance Ca-activated blocker | 0.059 0.043 CID_5896 | ||
| 0.062 | 0.045 | 0.062 | Carbonic anhydrase inhibitor | |||
| 0.024 | 0.008 | 0.024 | Apolipoprotein B-100 inhibitor | |||
| 0.036 | 0.02 | 0.036 | Melatonin 2 agonist | |||
| 0.025 | 0.01 | 0.025 | Apolipoprotein B inhibitor | |||
| 0.097 | 0.082 | 0.125 | DOPA decarboxylase inhibitor | 0.125 0.039 CID_14371 | CID_14371 | |
| 0.029 | 0.015 | 0.029 | Glucosylceramidase stimulant | |||
| 0.179 | 0.165 | 0.646 | Lipoxygenase inhibitor | 0.646 0.007 CID_5896 0.194 0.147 CID_154700124 0.306 0.068 CID_14371 | CID_5896 | |
| 0.044 | 0.03 | 0.044 | Histamine H1 receptor agonist | |||
| 0.039 | 0.025 | 0.039 | Glutamate (mGluR8) agonist | |||
| 0.032 | 0.018 | 0.032 | Purinergic P2Y14 antagonist | 0.028 0.025 CID_14371 | ||
| 0.048 | 0.035 | 0.048 | Carbonic anhydrase XIV inhibitor | 0.045 0.039 CID_14371 | ||
| 0.07 | 0.057 | 0.07 | Protein kinase B gamma inhibitor | |||
| 0.046 | 0.033 | 0.047 | Carbonic anhydrase VII inhibitor | 0.047 0.031 CID_14371 | CID_14371 | |
| 0.031 | 0.018 | 0.031 | Cyclin E2 inhibitor | 0.026 0.022 CID_14371 | ||
| 0.054 | 0.041 | 0.054 | Nicotinic neuronal receptor agonist | |||
| 0.017 | 0.005 | 0.017 | Carbonic anhydrase XI inhibitor | |||
| 0.037 | 0.025 | 0.037 | Inosine monophosphate dehydrogenase inhibitor | 0.037 0.024 CID_14371 | ||
| 0.053 | 0.041 | 0.053 | Carbonic anhydrase I inhibitor | |||
| 0.092 | 0.081 | 0.092 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.087 | 0.075 | 0.112 | Aminopeptidase B inhibitor | 0.112 0.057 CID_5896 | CID_5896 | |
| 0.052 | 0.042 | 0.052 | Carbonic anhydrase II inhibitor | |||
| 0.039 | 0.028 | 0.039 | Dihydropteroate synthase inhibitor | |||
| 0.025 | 0.015 | 0.025 | Glutamate (mGluR1) agonist | |||
| 0.048 | 0.038 | 0.048 | Cannabinoid CB2 receptor antagonist | |||
| 0.122 | 0.112 | 0.122 | Thiol protease inhibitor | |||
| 0.056 | 0.045 | 0.056 | Biliverdin reductase inhibitor | |||
| 0.065 | 0.055 | 0.065 | Prostaglandin-E synthase inhibitor | |||
| 0.04 | 0.03 | 0.04 | Histone deacetylase 8 inhibitor | |||
| 0.079 | 0.069 | 0.087 | Estrogen-related receptor beta agonist | 0.087 0.047 CID_14371 | CID_14371 | |
| 0.134 | 0.124 | 0.195 | DNA methyltransferase I inhibitor | 0.195 0.072 CID_14371 | CID_14371 | |
| 0.046 | 0.036 | 0.046 | Aldosterone antagonist | |||
| 0.1 | 0.091 | 0.112 | Microtubule formation inhibitor | 0.112 0.07 CID_154700124 0.102 0.086 CID_14371 | CID_154700124 | |
| 0.033 | 0.023 | 0.033 | Sirtuin 2 inhibitor | |||
| 0.07 | 0.061 | 0.07 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.068 | 0.059 | 0.068 | Phospholipase D inhibitor | |||
| 0.137 | 0.128 | 0.137 | Psychostimulant | |||
| 0.064 | 0.055 | 0.064 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.021 | 0.013 | 0.021 | Factor XIII inhibitor | |||
| 0.066 | 0.058 | 0.066 | Aminopeptidase I inhibitor | |||
| 0.033 | 0.025 | 0.033 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.071 | 0.062 | 0.071 | Glutamate receptor agonist | |||
| 0.114 | 0.106 | 0.114 | Nav1.6 sodium channel blocker | |||
| 0.015 | 0.007 | 0.05 | Human herpes virus 5 capsid protein P40 inhibitor | 0.05 0.003 CID_5896 | CID_5896 | |
| 0.014 | 0.006 | 0.014 | Melatonin 2 antagonist | |||
| 0.018 | 0.01 | 0.018 | Carbonic anhydrase X inhibitor | |||
| 0.018 | 0.01 | 0.018 | Carbonic anhydrase VIII inhibitor | |||
| 0.077 | 0.07 | 0.077 | GABA A receptor agonist | |||
| 0.076 | 0.069 | 0.076 | Bcr-Abl kinase inhibitor | |||
| 0.067 | 0.061 | 0.067 | Rho-associated kinase I inhibitor | |||
| 0.095 | 0.089 | 0.095 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.096 | 0.09 | 0.205 | Topoisomerase II inhibitor | 0.205 0.032 CID_14371 | CID_14371 | |
| 0.069 | 0.063 | 0.069 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.02 | 0.015 | 0.02 | Imidazoline I1 receptor antagonist | |||
| 0.023 | 0.018 | 0.023 | NMDA receptor glycine site antagonist | |||
| 0.058 | 0.053 | 0.058 | Phosphodiesterase 1C inhibitor | |||
| 0.097 | 0.092 | 0.097 | Proteasome inhibitor | |||
| 0.018 | 0.013 | 0.018 | Potassium channel (Inward rectifier) 11 blocker | |||
| 0.059 | 0.055 | 0.06 | Prolactin release inhibitor | 0.06 0.053 CID_14371 | CID_14371 | |
| 0.017 | 0.013 | 0.018 | Nicotinic acid receptor 1 antagonist | 0.018 0.012 CID_14371 | CID_14371 | |
| 0.054 | 0.049 | 0.054 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.071 | 0.067 | 0.071 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.083 | 0.079 | 0.095 | Protein kinase (CK2) inhibitor | 0.095 0.068 CID_14371 | CID_14371 | |
| 0.008 | 0.004 | 0.008 | DNA topoisomerase III inhibitor | |||
| 0.181 | 0.177 | 0.278 | Hypoxia-inducible factor 1 alpha inhibitor | 0.278 0.077 CID_14371 | CID_14371 | |
| 0.081 | 0.077 | 0.094 | ATPase (Vacuolar H+) inhibitor | 0.089 0.058 CID_154700124 0.094 0.048 CID_14371 | CID_14371 | |
| 0.038 | 0.034 | 0.07 | Dopamine D5 antagonist | 0.07 0.015 CID_14371 | CID_14371 | |
| 0.063 | 0.06 | 0.063 | Amidase inhibitor | |||
| 0.076 | 0.074 | 0.076 | Histamine H2 receptor antagonist | |||
| 0.053 | 0.05 | 0.061 | Botulinum neurotoxin type A inhibitor | 0.061 0.036 CID_14371 | CID_14371 | |
| 0.02 | 0.018 | 0.084 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.084 0.004 CID_14371 | CID_14371 | |
| 0.04 | 0.038 | 0.04 | Geranyltranstransferase inhibitor | |||
| 0.03 | 0.028 | 0.03 | Calcium release-activated channel blocker | |||
| 0.096 | 0.095 | 0.096 | TRKA antagonist | |||
| 0.061 | 0.059 | 0.061 | Potassium channel (ATP-sensitive) blocker | |||
| 0.051 | 0.05 | 0.051 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.065 | 0.064 | 0.065 | Glutamate dehydrogenase inhibitor | |||
| 0.038 | 0.038 | 0.053 | NMDA receptor subunit 3B antagonist | 0.04 0.035 CID_154700124 0.053 0.023 CID_14371 | CID_14371 | |
| 0.044 | 0.046 | 0.053 | Beta 2 adrenoreceptor antagonist | 0.053 0.032 CID_14371 | CID_14371 | |
| 0.073 | 0.075 | 0.084 | Glutathione S-transferase inhibitor | 0.084 0.056 CID_14371 | CID_14371 | |
| 0.07 | 0.073 | 0.085 | Adrenaline agonist | 0.085 0.052 CID_14371 | CID_14371 | |
| 0.05 | 0.054 | 0.075 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.075 0.027 CID_14371 | CID_14371 | |
| 0.041 | 0.046 | 0.045 | NMDA 2A receptor antagonist | 0.045 0.042 CID_14371 | CID_14371 | |
| 0.084 | 0.09 | 0.176 | Nav1.1 sodium channel blocker | 0.176 0.024 CID_154700124 | CID_154700124 | |
| 0.01 | 0.017 | 0.024 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.024 0.004 CID_5896 | CID_5896 | |
| 0.046 | 0.053 | 0.051 | Beta 1 adrenoreceptor antagonist | 0.051 0.046 CID_14371 | CID_14371 | |
| 0.085 | 0.093 | 0.142 | Estrogen receptor beta antagonist | 0.142 0.018 CID_14371 | CID_14371 | |
| 0.153 | 0.161 | 0.194 | Spasmolytic | 0.194 0.124 CID_14371 | CID_14371 | |
| 0.103 | 0.112 | 0.182 | Interleukin 4 antagonist | 0.182 0.029 CID_14371 | CID_14371 | |
| 0.087 | 0.096 | 0.186 | Toll-Like receptor 4 antagonist | 0.186 0.008 CID_154700124 0.1 0.069 CID_14371 | CID_154700124 | |
| 0.117 | 0.127 | 0.157 | Growth hormone agonist | 0.157 0.082 CID_154700124 0.122 0.118 CID_14371 | CID_154700124 | |
| 0.109 | 0.119 | 0.12 | Vanilloid 1 agonist | 0.12 0.087 CID_14371 | CID_14371 | |
| 0.095 | 0.107 | 0.235 | Tubulin antagonist | 0.235 0.028 CID_14371 | CID_14371 | |
| 0.076 | 0.088 | 0.087 | Alcohol dehydrogenase inhibitor | 0.087 0.069 CID_14371 | CID_14371 | |
| 0.05 | 0.063 | 0.096 | Heat shock protein 90 beta antagonist | 0.096 0.012 CID_14371 | CID_14371 | |
| 0.03 | 0.043 | 0.102 | Estradiol 17 beta-dehydrogenase inhibitor | 0.102 0.01 CID_14371 | CID_14371 | |
| 0.056 | 0.069 | 0.061 | Beta 2 adrenoreceptor agonist | 0.061 0.046 CID_14371 | CID_14371 | |
| 0.142 | 0.158 | 0.194 | Antiamyloidogenic | 0.194 0.104 CID_14371 | CID_14371 | |
| 0.107 | 0.122 | 0.131 | Cell wall synthesis inhibitor | 0.131 0.085 CID_14371 | CID_14371 | |
| 0.024 | 0.042 | 0.038 | Histone deacetylase 2 inhibitor | 0.038 0.019 CID_5896 | CID_5896 | |
| 0.053 | 0.073 | 0.078 | Histidine decarboxylase inhibitor | 0.078 0.044 CID_14371 | CID_14371 | |
| 0.025 | 0.045 | 0.036 | NMDA receptor subunit 3A antagonist | 0.034 0.031 CID_154700124 0.036 0.028 CID_14371 | CID_14371 | |
| 0.04 | 0.064 | 0.043 | Beta adrenoreceptor agonist | 0.043 0.042 CID_14371 | CID_14371 | |
| 0.079 | 0.103 | 0.089 | Interleukin 12 antagonist | 0.089 0.075 CID_14371 | CID_14371 | |
| 0.117 | 0.142 | 0.147 | Melanin inhibitor | 0.147 0.086 CID_14371 | CID_14371 | |
| 0.054 | 0.082 | 0.064 | Glutamate decarboxylase inhibitor | 0.064 0.063 CID_5896 | CID_5896 | |
| 0.063 | 0.091 | 0.103 | Estrogen receptor alpha antagonist | 0.103 0.025 CID_14371 | CID_14371 | |
| 0.012 | 0.041 | 0.022 | Histone deacetylase 1 inhibitor | 0.022 0.019 CID_5896 | CID_5896 | |
| 0.095 | 0.126 | 0.129 | Alkaline phosphatase inhibitor | 0.129 0.076 CID_14371 | CID_14371 | |
| 0.018 | 0.05 | 0.024 | Thyroid hormone agonist | 0.024 0.022 CID_14371 | CID_14371 | |
| 0.035 | 0.067 | 0.166 | Beta tubulin antagonist | 0.166 0.01 CID_14371 | CID_14371 | |
| 0.014 | 0.046 | 0.036 | Histone deacetylase 10 inhibitor | 0.036 0.018 CID_5896 | CID_5896 | |
| 0.077 | 0.111 | 0.165 | Cystathionine beta-synthase inhibitor | 0.165 0.035 CID_14371 | CID_14371 | |
| 0.119 | 0.154 | 0.174 | DNA methylase inhibitor | 0.174 0.097 CID_14371 | CID_14371 | |
| 0.044 | 0.08 | 0.079 | Dopamine D1 antagonist | 0.079 0.033 CID_14371 | CID_14371 | |
| 0.062 | 0.099 | 0.091 | Potassium channel (Ca-activated) activator | 0.091 0.063 CID_14371 | CID_14371 | |
| 0.011 | 0.053 | 0.016 | Antibiotic Tetracycline-like | 0.016 0.009 CID_154700124 0.015 0.011 CID_14371 | CID_154700124 | |
| 0.033 | 0.076 | 0.149 | Alpha tubulin antagonist | 0.149 0.009 CID_14371 | CID_14371 | |
| 0.087 | 0.132 | 0.145 | Estrogen antagonist | 0.145 0.025 CID_14371 | CID_14371 | |
| 0.103 | 0.154 | 0.229 | Amyloid beta aggregation inhibitor | 0.229 0.065 CID_14371 | CID_14371 | |
| 0.011 | 0.067 | 0.046 | Histone deacetylase 5 inhibitor | 0.046 0.018 CID_5896 | CID_5896 | |
| 0.173 | 0.228 | 0.321 | Sodium/bile acid cotransporter inhibitor | 0.321 0.061 CID_14371 | CID_14371 | |
| 0.18 | 0.237 | 0.299 | Alpha-glucosidase inhibitor | 0.299 0.16 CID_14371 | CID_14371 | |
| 0.126 | 0.184 | 0.172 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.172 0.116 CID_14371 | CID_14371 | |
| 0.015 | 0.077 | 0.035 | Histone deacetylase class IV inhibitor | 0.035 0.02 CID_5896 | CID_5896 | |
| 0.015 | 0.077 | 0.035 | Histone deacetylase 11 inhibitor | 0.035 0.02 CID_5896 | CID_5896 | |
| 0.011 | 0.076 | 0.025 | Dopamine D1 agonist | 0.025 0.012 CID_14371 | CID_14371 | |
| 0.072 | 0.137 | 0.165 | Amylase inhibitor | 0.165 0.057 CID_14371 | CID_14371 | |
| 0.152 | 0.22 | 0.189 | Cholesterol antagonist | 0.189 0.175 CID_14371 | CID_14371 | |
| 0.012 | 0.081 | 0.033 | Histone deacetylase 4 inhibitor | 0.033 0.022 CID_5896 | CID_5896 | |
| 0.023 | 0.095 | 0.039 | Acid-sensing ion channel blocker | 0.039 0.03 CID_5896 | CID_5896 | |
| 0.011 | 0.082 | 0.048 | Histone deacetylase class II inhibitor | 0.048 0.012 CID_5896 | CID_5896 | |
| 0.011 | 0.083 | 0.035 | Histone deacetylase class IIa inhibitor | 0.035 0.02 CID_5896 | CID_5896 | |
| 0.064 | 0.136 | 0.096 | DNA intercalator | 0.096 0.078 CID_14371 | CID_14371 | |
| 0.007 | 0.08 | 0.051 | Estrogen receptor beta agonist | 0.031 0.023 CID_154700124 0.051 0.019 CID_14371 | CID_14371 | |
| 0.018 | 0.091 | 0.075 | Dopamine D2 agonist | 0.075 0.015 CID_14371 | CID_14371 | |
| 0.055 | 0.129 | 0.679 | 5-Lipoxygenase inhibitor | 0.679 0.003 CID_5896 0.132 0.045 CID_14371 | CID_5896 | |
| 0.138 | 0.213 | 0.205 | Prostaglandin dehydrogenase inhibitor | 0.205 0.153 CID_14371 | CID_14371 | |
| 0.099 | 0.176 | 0.175 | Pyruvate kinase inhibitor | 0.175 0.097 CID_14371 | CID_14371 | |
| 0.062 | 0.141 | 0.081 | Thioredoxin reductase inhibitor | 0.081 0.06 CID_14371 | CID_14371 | |
| 0.009 | 0.088 | 0.041 | Histone deacetylase 6 inhibitor | 0.041 0.012 CID_5896 | CID_5896 | |
| 0.009 | 0.088 | 0.041 | Histone deacetylase class IIb inhibitor | 0.041 0.012 CID_5896 | CID_5896 | |
| 0.005 | 0.085 | 0.048 | Estrogen receptor alpha agonist | 0.042 0.02 CID_154700124 0.048 0.018 CID_14371 | CID_14371 | |
| 0.038 | 0.122 | 0.059 | Cyclin B3 inhibitor | 0.059 0.058 CID_14371 | CID_14371 | |
| 0.047 | 0.136 | 0.102 | Monophenol monooxygenase inhibitor | 0.102 0.074 CID_14371 | CID_14371 | |
| 0.036 | 0.126 | 0.055 | Transcription factor AP-1 inhibitor | 0.055 0.054 CID_154700124 | CID_154700124 | |
| 0.031 | 0.123 | 0.083 | Dopamine agonist | 0.083 0.035 CID_14371 | CID_14371 | |
| 0.013 | 0.107 | 0.066 | Estrogen agonist | 0.066 0.028 CID_14371 | CID_14371 | |
| 0.049 | 0.145 | 0.12 | Topoisomerase I inhibitor | 0.12 0.055 CID_14371 | CID_14371 | |
| 0.05 | 0.148 | 0.13 | Antineoplastic alkaloid | 0.13 0.034 CID_154700124 0.075 0.073 CID_14371 | CID_154700124 | |
| 0.01 | 0.109 | 0.062 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.062 0.01 CID_14371 | CID_14371 | |
| 0.013 | 0.113 | 0.085 | Opioid delta receptor agonist | 0.085 0.006 CID_154700124 | CID_154700124 | |
| 0.082 | 0.181 | 0.126 | Interleukin 2 antagonist | 0.126 0.037 CID_154700124 | CID_154700124 | |
| 0.063 | 0.163 | 0.102 | AMP-activated protein kinase stimulant | 0.102 0.068 CID_14371 | CID_14371 | |
| 0.168 | 0.271 | 0.291 | Antibacterial | 0.291 0.142 CID_14371 | CID_14371 | |
| 0.082 | 0.184 | 0.149 | Protein-tyrosine phosphatase inhibitor | 0.149 0.079 CID_14371 | CID_14371 | |
| 0.094 | 0.2 | 0.16 | Dual specificity phosphatase inhibitor | 0.16 0.083 CID_14371 | CID_14371 | |
| 0.059 | 0.171 | 0.088 | Xanthine oxidase inhibitor | 0.088 0.074 CID_14371 | CID_14371 | |
| 0.067 | 0.18 | 0.167 | Lipid peroxidase inhibitor | 0.136 0.079 CID_5896 0.167 0.057 CID_14371 | CID_14371 | |
| 0.111 | 0.226 | 0.364 | Vasodilator | 0.364 0.03 CID_5896 0.188 0.114 CID_14371 | CID_5896 | |
| 0.075 | 0.204 | 0.199 | Neurotrophic factor | 0.199 0.028 CID_154700124 | CID_154700124 | |
| 0.038 | 0.171 | 0.103 | CDC25A inhibitor | 0.103 0.026 CID_14371 | CID_14371 | |
| 0.035 | 0.169 | 0.342 | Analgesic, opioid | 0.342 0.005 CID_154700124 | CID_154700124 | |
| 0.031 | 0.164 | 0.067 | CDC25B inhibitor | 0.067 0.041 CID_14371 | CID_14371 | |
| 0.053 | 0.206 | 0.256 | Cyclooxygenase 1 inhibitor | 0.256 0.02 CID_5896 | CID_5896 | |
| 0.042 | 0.196 | 0.387 | Opioid kappa receptor antagonist | 0.387 0.004 CID_154700124 | CID_154700124 | |
| 0.018 | 0.173 | 0.285 | Opioid mu receptor antagonist | 0.285 0.005 CID_154700124 | CID_154700124 | |
| 0.017 | 0.173 | 0.26 | Opioid delta receptor antagonist | 0.26 0.005 CID_154700124 | CID_154700124 | |
| 0.142 | 0.299 | 0.282 | Caspase 3 stimulant | 0.282 0.089 CID_14371 | CID_14371 | |
| 0.037 | 0.2 | 0.35 | Opioid antagonist | 0.35 0.005 CID_154700124 | CID_154700124 | |
| 0.165 | 0.33 | 0.369 | Apoptosis agonist | 0.31 0.165 CID_154700124 0.369 0.129 CID_14371 | CID_14371 | |
| 0.013 | 0.182 | 0.096 | Opioid kappa receptor agonist | 0.096 0.01 CID_154700124 | CID_154700124 | |
| 0.013 | 0.189 | 0.291 | Opioid agonist | 0.291 0.004 CID_154700124 | CID_154700124 | |
| 0.005 | 0.181 | 0.047 | Aggrecanase 2 inhibitor | 0.047 0.005 CID_5896 | CID_5896 | |
| 0.01 | 0.188 | 0.166 | Opioid mu receptor agonist | 0.166 0.005 CID_154700124 | CID_154700124 | |
| 0.02 | 0.205 | 0.067 | HIV-1 integrase (3'-Processing) inhibitor | 0.067 0.041 CID_14371 | CID_14371 | |
| 0.07 | 0.267 | 0.193 | Antimitotic | 0.193 0.088 CID_154700124 0.139 0.134 CID_14371 | CID_154700124 | |
| 0.05 | 0.254 | 0.23 | Cyclooxygenase inhibitor | 0.23 0.031 CID_5896 | CID_5896 | |
| 0.04 | 0.249 | 0.102 | Chelator | 0.102 0.075 CID_14371 | CID_14371 | |
| 0.039 | 0.259 | 0.183 | Cyclooxygenase 2 inhibitor | 0.183 0.036 CID_5896 | CID_5896 | |
| 0.124 | 0.344 | 0.193 | Apoptosis antagonist | 0.193 0.189 CID_14371 | CID_14371 | |
| 0.026 | 0.26 | 0.135 | M18 aspartyl aminopeptidase inhibitor | 0.135 0.06 CID_14371 | CID_14371 | |
| 0.012 | 0.26 | 0.051 | HIV-1 integrase (Strand Transfer) inhibitor | 0.051 0.049 CID_14371 | CID_14371 | |
| 0.016 | 0.267 | 0.034 | ADAM10 endopeptidase inhibitor | 0.034 0.022 CID_5896 | CID_5896 | |
| 0.048 | 0.301 | 0.138 | Angiogenesis stimulant | 0.138 0.131 CID_14371 | CID_14371 | |
| 0.06 | 0.335 | 0.249 | Free radical scavenger | 0.249 0.069 CID_14371 | CID_14371 | |
| 0.067 | 0.348 | 0.256 | Antioxidant | 0.256 0.08 CID_14371 | CID_14371 | |
| 0.109 | 0.4 | 0.714 | Analgesic | 0.714 0.012 CID_154700124 | CID_154700124 | |
| 0.077 | 0.385 | 0.391 | Immunosuppressant | 0.391 0.067 CID_154700124 | CID_154700124 | |
| 0.05 | 0.365 | 0.175 | Nitric oxide antagonist | 0.175 0.079 CID_154700124 0.134 0.112 CID_14371 | CID_154700124 | |
| 0.015 | 0.335 | 0.122 | Leukotriene synthesis inhibitor | 0.122 0.016 CID_5896 | CID_5896 | |
| 0.015 | 0.335 | 0.201 | Aggrecanase 1 inhibitor | 0.201 0.004 CID_5896 | CID_5896 | |
| 0.048 | 0.459 | 0.136 | Hepatoprotectant | 0.136 0.125 CID_14371 | CID_14371 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |